tirzepatide uric acid levels study Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Tirzepatide: A Systematic Update
Description
Heres exactly how it works

Why Choose IconMD for Weight Loss Treatment
The startup's website says it can "guide" patients to low-cost generic medications for weight loss if their insurance doesn't cover the cost of the GLP-1s

Tirzepatide, the main ingredient in Zepbound and the diabetes drug Mounjaro, targets both GLP-1 and GIP

This difference primarily stems from bioavailability: injectable semaglutide enters circulation directly, while oral semaglutide faces significant absorption challenges in the digestive tract

doi: 10.1136/jim-2021-001931
